Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions
Authors:
- 27 March 2025
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 66 (5) , 793-794
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Irradiated tumour cell-derived microparticles upregulate MHC-I expression in cancer cells via DNA double-strand break repair pathwayCancer Letters, 2024
- Membrane and Nuclear Absorbed Doses from177Lu and161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo StudyJournal of Nuclear Medicine, 2023
- Tumor immune evasion through loss of MHC class-I antigen presentationCurrent Opinion in Immunology, 2023
- Ionizing Radiation Drives Key Regulators of Antigen Presentation and a Global Expansion of the ImmunopeptidomeMolecular & Cellular Proteomics, 2022
- Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapyJournal for ImmunoTherapy of Cancer, 2021
- Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyCancer Discovery, 2021
- Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeScience Translational Medicine, 2021
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic TumorsImmunity, 2014
- The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell–Mediated KillingClinical Cancer Research, 2008
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006